Lv1
32 积分 2025-09-02 加入
Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial
44分钟前
待确认
Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer
51分钟前
已完结
Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy
1个月前
已完结
Clinical toxicity of ADCs and ICI–ADC combinations: mechanisms, patterns and management
2个月前
已完结
Interstitial Lung Disease: A Review
1年前
已完结
皖公网安备34019202002308
